Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Current Leases (2020 - 2025)

Immucell (ICCC) has disclosed Current Leases for 6 consecutive years, with $82442.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases fell 82.9% year-over-year to $82442.0, compared with a TTM value of $82442.0 through Sep 2025, down 82.9%, and an annual FY2024 reading of $432072.0, down 32.94% over the prior year.
  • Current Leases was $82442.0 for Q3 2025 at Immucell, down from $322753.0 in the prior quarter.
  • Across five years, Current Leases topped out at $644276.0 in Q4 2023 and bottomed at $22920.0 in Q3 2022.
  • Average Current Leases over 5 years is $227735.4, with a median of $108012.0 recorded in 2021.
  • The sharpest move saw Current Leases surged 1928.32% in 2023, then plummeted 82.9% in 2025.
  • Year by year, Current Leases stood at $108012.0 in 2021, then tumbled by 70.59% to $31764.0 in 2022, then soared by 1928.32% to $644276.0 in 2023, then crashed by 32.94% to $432072.0 in 2024, then plummeted by 80.92% to $82442.0 in 2025.
  • Business Quant data shows Current Leases for ICCC at $82442.0 in Q3 2025, $322753.0 in Q2 2025, and $380958.0 in Q1 2025.